This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
MONDAY, May 6, 2024 -- Scientists are busy working on a vaccine that might fight strains of the COVID virus SARS-CoV-2 that haven't even emerged yet.The effort from a British team at the University of Cambridge is already showing promise in mouse.
10, 2023 (Healthday News) -- The first vaccine to prevent infection with the chikungunya virus was approved by the U.S. FRIDAY, Nov. Food and Drug Administration on Thursday. The single-dose shot, known as Ixchiq, is approved for adults who are at.
TUESDAY, May 21, 2024 -- Powerful COVID vaccines could be setting people’s immune systems up to successfully fight off not just future COVID variants, but other types of coronaviruses as well, a new study shows.People repeatedly vaccinated for.
1, 2024 -- A next-generation nasal vaccine for COVID-19 appears to do what injectable vaccines can’t -- actually stop the spread of the virus from person to person.Hamsters that received the nasal vaccine didn’t pass the virus on to. THURSDAY, Aug.
Those with aging immune systems struggle to fight off novel viruses and respond weakly to vaccination. Researchers were able to revitalize the immune system in mice.
27, 2024 -- More Americans believe in the effectiveness of vaccines developed to protect newborns and seniors against respiratory syncytial virus (RSV).More adults (52%) think the RSV vaccine given to pregnant women. FRIDAY, Dec. More than half of U.S.
1, 2024 -- A rare, highly contagious Ebola-like virus has claimed eight lives in Rwanda, and U.S. health officials are closely monitoring the outbreak.Marburg virus causes a rare hemorrhagic fever that has no authorized vaccine or. TUESDAY, Oct.
FRIDAY, May 24, 2024 -- Development and uptake of the human papilloma virus (HPV) vaccine has been crucial in reducing rates of virus-linked cervical cancers in women. Now, the accumulated data suggests the vaccine is saving men from fatal cancers.
18, 2024 -- A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% protection against severe illness and/or hospitalization.With U.S. vaccination rates falling, "I. FRIDAY, Oct.
TUESDAY, July 9, 2024 -- Expectant mothers who get vaccinated to protect their newborns against respiratory syncytial virus (RSV) are not putting themselves or their babies at risk, new research affirms. It found that getting the shot during late.
4, 2024 -- Current vaccines against mpox were designed to fight an older, rarer cousin of the virus, smallpox.Now, new research from the drug company Moderna suggests its new mpox vaccine, based on mRNA technology, might do a. WEDNESDAY, Sept.
Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness. MONDAY, June 10, 2024 -- The U.S. Drugmaker GSK's.
TUESDAY, July 9, 2024 -- Expectant mothers who get vaccinated to protect their newborns against respiratory syncytial virus (RSV) are not putting themselves or their babies at risk, new research affirms.It found that getting the shot during late.
TUESDAY, April 16, 2024 -- Genetics-based “one-and-done” vaccines for the flu and COVID could prove more effective and easier to craft than current jabs, researchers report.These new vaccines would target viruses using a different response to.
18, 2024 -- A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% protection against severe illness and/or hospitalization. vaccination rates falling, "I. FRIDAY, Oct.
Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness. MONDAY, June 10, 2024 -- The U.S. Drugmaker GSK's.
THURSDAY, June 29, 2023 -- Americans ages 60 and up can get their vaccine for respiratory syncytial virus (RSV) this fall, the U.S. Centers for Disease Control and Prevention announced Thursday. On Thursday, Dr. Rochelle Walensky, the outgoing CDC.
28, 2023 -- About half of older adults (52 percent) have heard of the new vaccines against respiratory syncytial virus (RSV), Arexvy and Abrysvo, according to the National Poll on Healthy Aging released online on Aug. MONDAY, Aug. The poll,
GSK expects its respiratory syncytial virusvaccine will be a multibillion dollar product. But at the beginning it’s predicting a slower launch than for its fast-selling shingles shot.
Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats. Others, including GSK and Pfizer, are also at work on similar shots.
7, 2023 -- While it doesn't prevent infection altogether, new research shows the mpox vaccine does reduces the severity of disease in those who fall ill from the virus. THURSDAY, Sept. An international team of scientists found that those people who.
An experimental influenza vaccine carrying more than 80,000 variations of hemagglutinin antigens caused the immune system of mice and ferrets to respond more strongly to less variable portions of the virus. This is a big step forward in efforts at the Duke Human Vaccine Institute to develop a universal, long-lasting flu shot.
22, 2023 -- Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV). FRIDAY, Sept. Following approval one month ago by the U.S. Food and Drug Administration, the Centers for.
The approval of both reformulated messenger RNA vaccines, which are designed to target the KP.2 2 virus strain, comes just ahead of the fall and winter seasons.
THURSDAY, July 18, 2024 -- You're far less likely to develop Long COVID now than you were in the midst of the pandemic, promising new data shows.Changes in strains of SARS-CoV-2, the virus that causes COVID-19, are playing a role in the lowered.
29, 2023 – When pregnant women get a COVID vaccine, it helps protect their newborns from the virus, a new government study shows. These findings indicate that maternal vaccination during pregnancy could help prevent. FRIDAY, Sept.
22, 2023 -- Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV), following U.S. TUESDAY, Aug. Food and Drug Administration approval of the shot, called Abrysvo, on.
22, 2023 -- Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV), following U.S. TUESDAY, Aug. Food and Drug Administration approval of the shot, called Abrysvo, on.
18, 2023 -- Most parents plan to have their kids vaccinated against influenza and respiratory syncytial virus (RSV), even as COVID-19 vaccine acceptance flags, a new poll finds.Seven in 10 parents (71%) plan to have their children get. MONDAY, Dec.
26, 2023 -- Measles is incredibly contagious, and outbreaks are more common now as people decide against vaccinating their kids. Now, a case involving a rare but fatal brain disease caused by the measles virus may make some rethink. TUESDAY, Dec.
9, 2023 -- The best way to prevent cervical cancer in women is to give HPV vaccines to both boys and girls, a new study argues. That way, herd immunity could help eradicate the cancer-causing virus, researchers say. THURSDAY, Nov. Cancer-related.
The shot, which the Danish company acquired from Emergent BioSolutions, spurred protective antibodies against the mosquito-borne virus in older adults.
The expert panel recommended coronavirus vaccines be tailored to target an omicron subvariant known as XBB, which Pfizer, Moderna and Novavax said they’re prepared to do.
said Wednesday that its updated vaccine held its own against this highly mutated version of the virus. WEDNESDAY, Sept. 6, 2023 -- Some good news for folks who are worried about the new, troublesome COVID variant known as BA.2.86: 2.86: Moderna Inc.
Food and Drug Administration advisory panel on Thursday recommended that the agency approve an RSV vaccine for infants and some toddlers. The monoclonal antibody shot would protect against respiratory syncytial virus. FRIDAY, June 9, 2023 – A U.S.
WEDNESDAY, May 1, 2024 -- Getting the HPV shot in adolescence can spare kids a lifetime of risk for cervical and other cancers related to the virus, but only half of American kids are up-to-date on these shots.Now, a new review suggests that if.
THURSDAY, June 29, 2023 -- Americans ages 60 and up can get their vaccine for respiratory syncytial virus (RSV) this fall, the U.S. Centers for Disease Control and Prevention announced Thursday. On Thursday, Dr. Rochelle Walensky, the outgoing CDC.
In a new development, a recent paper published in Biology Methods & Protocols by Oxford University Press has highlighted a promising avenue for enhancing vaccine efficacy against infectious pathogens like the COVID-19 virus. Since December 2019, SARS-CoV-2 (COVID-19) infection has become a worldwide urgent public health concern.
A University of Queensland developed vaccine will protect farmed saltwater crocodiles from West Nile virus (WNV), providing economic and biodiversity benefits to northern Australia.
CPI today announced a partnership with Excivion Ltd, Cambridge, to optimise the manufacture of their novel Zika vaccine antigen candidate, Zika-HX, an integral component of any future vaccine formulation.
OVO Biomanufacturing, a spin-out from the University of Warwick and Coventry University, is developing digital solutions to improve the efficiency of viral vaccine and gene therapy manufacture. The technology can be applied to any virus that is grown to produce a vaccine or therapy.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content